- Tytuł :
- Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- Autorzy :
- Źródło :
- In The Lancet HIV December 2017 4(12):e536-e546
-
Czasopismo naukowe